| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.
|
Diabetes Care
|
1993
|
17.66
|
|
2
|
Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.
|
Lancet
|
1986
|
7.35
|
|
3
|
Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).
|
JAMA
|
1986
|
5.15
|
|
4
|
End-stage renal disease in African-American and white men. 16-year MRFIT findings.
|
JAMA
|
1997
|
5.09
|
|
5
|
An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status.
|
Am J Public Health
|
1983
|
4.36
|
|
6
|
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.
|
N Engl J Med
|
1989
|
4.31
|
|
7
|
Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.
|
JAMA
|
1982
|
4.25
|
|
8
|
Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group.
|
JAMA
|
1990
|
3.85
|
|
9
|
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.
|
Am J Epidemiol
|
1996
|
3.82
|
|
10
|
Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.
|
Arch Intern Med
|
1992
|
3.81
|
|
11
|
Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial.
|
Lancet
|
1998
|
3.79
|
|
12
|
Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
|
Arch Intern Med
|
1992
|
3.42
|
|
13
|
Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years.
|
Am Heart J
|
1984
|
3.25
|
|
14
|
Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial.
|
JAMA
|
1987
|
3.25
|
|
15
|
The multiple risk factor intervention trial (MRFIT) II. The development of the protocol.
|
Prev Med
|
1981
|
3.02
|
|
16
|
Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group.
|
Ann Intern Med
|
1992
|
2.96
|
|
17
|
Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.
|
Circulation
|
1990
|
2.68
|
|
18
|
Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial.
|
Am Heart J
|
1986
|
2.55
|
|
19
|
The multiple risk factor intervention trial (MRFIT). V. Intervention on smoking.
|
Prev Med
|
1981
|
2.47
|
|
20
|
Long-term cardiovascular mortality among middle-aged men with gout.
|
Arch Intern Med
|
2008
|
2.32
|
|
21
|
Chronic kidney disease and the risk of incident gout among middle-aged men: a seven-year prospective observational study.
|
Arthritis Rheum
|
2013
|
2.19
|
|
22
|
Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.
|
JAMA
|
1997
|
2.06
|
|
23
|
Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality.
|
JAMA
|
1985
|
1.97
|
|
24
|
Effects of passive smoking in the Multiple Risk Factor Intervention Trial.
|
Am J Epidemiol
|
1987
|
1.93
|
|
25
|
Baseline factors associated with smoking cessation and relapse. MRFIT Research Group.
|
Prev Med
|
1991
|
1.93
|
|
26
|
Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT).
|
Circulation
|
1987
|
1.92
|
|
27
|
Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial.
|
JAMA
|
1987
|
1.86
|
|
28
|
The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease.
|
Am J Epidemiol
|
1985
|
1.74
|
|
29
|
Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.
|
Ann Intern Med
|
2005
|
1.71
|
|
30
|
Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial.
|
Circulation
|
1996
|
1.56
|
|
31
|
The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT).
|
Am J Public Health
|
1990
|
1.48
|
|
32
|
Cigarette smoking and mortality. MRFIT Research Group.
|
Prev Med
|
1991
|
1.45
|
|
33
|
Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial.
|
Ann Intern Med
|
1993
|
1.45
|
|
34
|
Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT).
|
Am J Epidemiol
|
1990
|
1.36
|
|
35
|
Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial.
|
Am J Epidemiol
|
1996
|
1.35
|
|
36
|
Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial.
|
Circulation
|
1988
|
1.35
|
|
37
|
Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial.
|
Am Heart J
|
1984
|
1.33
|
|
38
|
The multiple risk factor intervention trial (MRFIT). A national study of primary prevention of coronary heart disease.
|
JAMA
|
1976
|
1.30
|
|
39
|
Prognostic associations of Minnesota Code serial electrocardiographic change classification with coronary heart disease mortality in the Multiple Risk Factor Intervention Trial.
|
Am J Cardiol
|
1997
|
1.29
|
|
40
|
Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial.
|
Am J Cardiol
|
1986
|
1.24
|
|
41
|
Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group.
|
Circulation
|
1995
|
1.21
|
|
42
|
Nutrition data collection in the Multiple Risk Factor Intervention Trial (MRFIT). Baseline nutrient intake of a randomized population.
|
J Am Diet Assoc
|
1981
|
1.21
|
|
43
|
Relationship to blood pressure of combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention Trial (MRFIT).
|
Circulation
|
1996
|
1.18
|
|
44
|
Leisure time physical activity and the 16-year risks of mortality from coronary heart disease and all-causes in the Multiple Risk Factor Intervention Trial (MRFIT).
|
Int J Sports Med
|
1997
|
1.18
|
|
45
|
Recruitment of participants for the multiple risk factor intervention trial (MRFIT).
|
Control Clin Trials
|
1987
|
1.18
|
|
46
|
Evaluation of two biological markers of tobacco exposure. MRFIT Research Group.
|
Prev Med
|
1991
|
1.17
|
|
47
|
Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT).
|
Int J Epidemiol
|
1998
|
1.14
|
|
48
|
The NHLBI nutrition data system.
|
J Am Diet Assoc
|
1980
|
1.13
|
|
49
|
The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial.
|
Am J Epidemiol
|
1991
|
1.12
|
|
50
|
Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial.
|
Am J Cardiol
|
1987
|
1.12
|
|
51
|
Method issues in dietary data analyses in the Multiple Risk Factor Intervention Trial.
|
Am J Clin Nutr
|
1997
|
1.12
|
|
52
|
Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial.
|
Am J Epidemiol
|
1996
|
1.09
|
|
53
|
Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT).
|
World Rev Nutr Diet
|
1991
|
1.08
|
|
54
|
Assessing dietary adherence in the Multiple Risk Factor Intervention Trial (MRFIT). I. Use of a dietary monitoring tool.
|
J Am Diet Assoc
|
1980
|
1.07
|
|
55
|
Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
|
Prev Med
|
1986
|
1.06
|
|
56
|
Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.
|
Diabetes Metab Syndr Obes
|
2014
|
1.05
|
|
57
|
Stressful life events, Type A behavior, and the prediction of cardiovascular and total mortality over six years. MRFIT Group.
|
J Behav Med
|
1990
|
1.04
|
|
58
|
Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study.
|
Am J Kidney Dis
|
1993
|
1.03
|
|
59
|
The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial.
|
Am Rev Respir Dis
|
1989
|
1.03
|
|
60
|
The multiple risk factor intervention trial (MRFIT). VII. A comparison of risk factor changes between the two study groups.
|
Prev Med
|
1981
|
1.03
|
|
61
|
Does switching from cigarettes to pipes or cigars reduce tobacco smoke exposure?
|
Am J Public Health
|
1987
|
1.02
|
|
62
|
Physical activity and 10.5 year mortality in the Multiple Risk Factor Intervention Trial (MRFIT).
|
Int J Epidemiol
|
1991
|
1.02
|
|
63
|
Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial.
|
Am J Clin Nutr
|
1997
|
1.01
|
|
64
|
Comparison of smoking behavior change for SI and UC study groups. MRFIT Research Group.
|
Prev Med
|
1991
|
1.01
|
|
65
|
Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
|
Am J Cardiol
|
1986
|
1.00
|
|
66
|
Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial.
|
Am J Med
|
1984
|
0.99
|
|
67
|
Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial.
|
Am J Med
|
1986
|
0.99
|
|
68
|
Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
|
Am J Cardiol
|
1985
|
0.99
|
|
69
|
Smoking cessation and change in diastolic blood pressure, body weight, and plasma lipids. MRFIT Research Group.
|
Prev Med
|
1991
|
0.96
|
|
70
|
Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience.
|
J Am Coll Cardiol
|
1986
|
0.96
|
|
71
|
Usefulness of sex steroid hormone levels in predicting coronary artery disease in men.
|
Am J Cardiol
|
1987
|
0.95
|
|
72
|
Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups.
|
Arch Intern Med
|
1985
|
0.94
|
|
73
|
Comparison of patterns of smoking behavior change among smokers in the Multiple Risk Factor Intervention Trial (MRFIT).
|
Prev Med
|
1982
|
0.94
|
|
74
|
The multiple risk factor intervention trial (MRFIT). III. The model for intervention.
|
Prev Med
|
1981
|
0.94
|
|
75
|
Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial.
|
Ann Epidemiol
|
1997
|
0.93
|
|
76
|
Assessing dietary adherence in the Multiple Risk Factor Intervention Trial (MRFIT). II. Food record rating as an indicator of compliance.
|
J Am Diet Assoc
|
1980
|
0.92
|
|
77
|
Methods of dietary and nutritional assessment and intervention and other methods in the Multiple Risk Factor Intervention Trial.
|
Am J Clin Nutr
|
1997
|
0.91
|
|
78
|
Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). The Multiple Risk Factor Intervention Trial Group.
|
J Chronic Dis
|
1977
|
0.91
|
|
79
|
Quality control of screening procedures in the Multiple Risk Factor Intervention Trial.
|
Control Clin Trials
|
1986
|
0.91
|
|
80
|
Pulmonary function in relation to cigarette smoking and smoking cessation. MRFIT Research Group.
|
Prev Med
|
1991
|
0.91
|
|
81
|
Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial.
|
Am J Cardiol
|
1989
|
0.91
|
|
82
|
Prospective association between lipid soluble antioxidants and coronary heart disease in men. The Multiple Risk Factor Intervention Trial.
|
Am J Epidemiol
|
1998
|
0.91
|
|
83
|
Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial.
|
Ann Epidemiol
|
1994
|
0.91
|
|
84
|
Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.
|
Prev Med
|
1985
|
0.90
|
|
85
|
Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group.
|
Ann Epidemiol
|
1993
|
0.90
|
|
86
|
Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
|
Am J Cardiol
|
1985
|
0.90
|
|
87
|
The effect of modified limb electrode positions on electrocardiographic wave amplitudes.
|
J Electrocardiol
|
1980
|
0.89
|
|
88
|
Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial. The MRFIT Research Group.
|
Prev Med
|
1991
|
0.88
|
|
89
|
Risk factors for the development of type II diabetes among men enrolled in the usual care group of the Multiple Risk Factor Intervention Trial.
|
Diabetes Care
|
1993
|
0.88
|
|
90
|
The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipids.
|
Prev Med
|
1981
|
0.88
|
|
91
|
A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). The MRFIT Research Group.
|
Control Clin Trials
|
1991
|
0.88
|
|
92
|
Adherence to dietary recommendations in the special intervention group in the Multiple Risk Factor Intervention Trial.
|
Am J Clin Nutr
|
1997
|
0.87
|
|
93
|
Quality control of biochemical data in the Multiple Risk Factor Intervention Trial: Central Laboratory.
|
Control Clin Trials
|
1986
|
0.87
|
|
94
|
Dietary intake in the Multiple Risk Factor Intervention Trial (MRFIT): nutrient and food group changes over 6 years.
|
J Am Diet Assoc
|
1986
|
0.86
|
|
95
|
HDL-cholesterol levels in the Multiple Risk Factor Intervention Trial (MRFIT) by the MRFIT Research Group 1,2.
|
Lipids
|
1979
|
0.86
|
|
96
|
Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial.
|
Am J Epidemiol
|
1994
|
0.86
|
|
97
|
Primary prevention of heart attacks: the multiple risk factor intervention trial.
|
Am J Epidemiol
|
1980
|
0.85
|
|
98
|
Quality control in the Multiple Risk Factor Intervention Trial Nutrition Modality.
|
Control Clin Trials
|
1986
|
0.85
|
|
99
|
Quality control aspects of blood pressure measurements in the Multiple Risk Factor Intervention Trial.
|
Control Clin Trials
|
1986
|
0.84
|
|
100
|
Relation of smoking at baseline and during trial years 1-6 to food and nutrient intakes and weight in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial.
|
Am J Clin Nutr
|
1997
|
0.83
|